BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

EndoChoice Files Suit for Patent Infringement


12/15/2011 9:12:29 AM

ALPHARETTA, GA--(Marketwire - December 15, 2011) -

EndoChoice, Inc. announced today it has filed a Complaint against Austin Medical, Inc., AVID Medical, Inc., and Cygnus Medical LLC, in the U.S. District Court for the Northern District of Georgia, alleging that each defendant makes and/or sells a scope transport pad that infringes EndoChoice's U.S. Patent No. 8,042,688 (the '688 patent). The '688 patent was issued by the U.S. Patent and Trademark Office in 2011 and covers EndoChoice's innovative Cinchpad® product.

In its Complaint, EndoChoice alleges the Scope Transport Pad sold by each of the defendants, as well as the Kangaroo™ Transport Pad sold by Cygnus Medical, infringes EndoChoice's '688 patent. The Complaint seeks damages as a result of the defendants' infringement of the '688 patent, as well as a preliminary and a permanent injunction against any further infringement of the '688 patent.

EndoChoice's proprietary CinchPad® combines an absorbent pad and impermeable membrane, protecting the work surface and equipment during a gastrointestinal (GI) procedure. The drawstring feature enables staff to easily enclose the contaminated GI endoscope during transport.

"EndoChoice recognized that GI facilities needed a way to meet stringent society guidelines that were developed to prevent cross-contamination and protect staff," said Will Parks, EndoChoice's Co-Founder and VP of Product Development. "The CinchPad® is becoming a procedural staple due to its proprietary technology facilitating standardization and compliance. The related '688 patent is valuable intellectual property that is the product of EndoChoice's ongoing innovations in the field of GI endoscopy."

About EndoChoice
EndoChoice is a leading medical technology provider dedicated to meeting the need of specialists treating a wide range of gastrointestinal diseases. EndoChoice is committed to the GI endoscopy market, offering a comprehensive portfolio of devices, infection prevention and diagnostic products and services. For more information, visit www.EndoChoice.com.


Contact:
Scott Fraser
Vice President of Marketing
770-682-8700
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES